Compared with macrophages in normal tissue, pancreatic cancer patients exhibited high expression of C1QB in TAMs and peripheral blood (72), indicating that it may be a suitable liquid biopsy biomarker to predict prognosis. This evidence concerns the gene C1QB and pancreatic neoplasm.